156 related articles for article (PubMed ID: 17881586)
21. Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations.
Wagner KR; Hamed S; Hadley DW; Gropman AL; Burstein AH; Escolar DM; Hoffman EP; Fischbeck KH
Ann Neurol; 2001 Jun; 49(6):706-11. PubMed ID: 11409421
[TBL] [Abstract][Full Text] [Related]
22. A breakthrough in readthrough? Could geneticin lead the way to effective treatment for cystinosis nonsense mutations?
Midgley J
Pediatr Nephrol; 2019 May; 34(5):917-920. PubMed ID: 30623245
[No Abstract] [Full Text] [Related]
23. Suppression of nonsense mutations in Rett syndrome by aminoglycoside antibiotics.
Brendel C; Klahold E; Gärtner J; Huppke P
Pediatr Res; 2009 May; 65(5):520-3. PubMed ID: 19190538
[TBL] [Abstract][Full Text] [Related]
24. Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations.
Nudelman I; Glikin D; Smolkin B; Hainrichson M; Belakhov V; Baasov T
Bioorg Med Chem; 2010 Jun; 18(11):3735-46. PubMed ID: 20409719
[TBL] [Abstract][Full Text] [Related]
25. Polyamine-responsive ribosomal arrest at the stop codon of an upstream open reading frame of the AdoMetDC1 gene triggers nonsense-mediated mRNA decay in Arabidopsis thaliana.
Uchiyama-Kadokura N; Murakami K; Takemoto M; Koyanagi N; Murota K; Naito S; Onouchi H
Plant Cell Physiol; 2014 Sep; 55(9):1556-67. PubMed ID: 24929422
[TBL] [Abstract][Full Text] [Related]
26. Rescue of melanocortin 4 receptor (MC4R) nonsense mutations by aminoglycoside-mediated read-through.
Brumm H; Mühlhaus J; Bolze F; Scherag S; Hinney A; Hebebrand J; Wiegand S; Klingenspor M; Grüters A; Krude H; Biebermann H
Obesity (Silver Spring); 2012 May; 20(5):1074-81. PubMed ID: 21738238
[TBL] [Abstract][Full Text] [Related]
27. PTC124-mediated translational readthrough of a nonsense mutation causing Usher syndrome type 1C.
Goldmann T; Overlack N; Wolfrum U; Nagel-Wolfrum K
Hum Gene Ther; 2011 May; 22(5):537-47. PubMed ID: 21235327
[TBL] [Abstract][Full Text] [Related]
28. Aminoglycoside-mediated partial suppression of MECP2 nonsense mutations responsible for Rett syndrome in vitro.
Popescu AC; Sidorova E; Zhang G; Eubanks JH
J Neurosci Res; 2010 Aug; 88(11):2316-24. PubMed ID: 20623622
[TBL] [Abstract][Full Text] [Related]
29. Drug-induced readthrough of premature stop codons leads to the stabilization of laminin alpha2 chain mRNA in CMD myotubes.
Allamand V; Bidou L; Arakawa M; Floquet C; Shiozuka M; Paturneau-Jouas M; Gartioux C; Butler-Browne GS; Mouly V; Rousset JP; Matsuda R; Ikeda D; Guicheney P
J Gene Med; 2008 Feb; 10(2):217-24. PubMed ID: 18074402
[TBL] [Abstract][Full Text] [Related]
30. Baby, don't stop!
Mankin AS; Liebman SW
Nat Genet; 1999 Sep; 23(1):8-10. PubMed ID: 10471486
[No Abstract] [Full Text] [Related]
31. Pharmaceutical therapies to recode nonsense mutations in inherited diseases.
Lee HL; Dougherty JP
Pharmacol Ther; 2012 Nov; 136(2):227-66. PubMed ID: 22820013
[TBL] [Abstract][Full Text] [Related]
32. Analysis of aberrant splicing and nonsense-mediated decay of the stop codon mutations c.109G>T and c.504_505delCT in 7 patients with HMG-CoA lyase deficiency.
Puisac B; Teresa-Rodrigo ME; Arnedo M; Gil-Rodríguez MC; Pérez-Cerdá C; Ribes A; Pié A; Bueno G; Gómez-Puertas P; Pié J
Mol Genet Metab; 2013 Apr; 108(4):232-40. PubMed ID: 23465862
[TBL] [Abstract][Full Text] [Related]
33. Restoration of APC gene function in colorectal cancer cells by aminoglycoside- and macrolide-induced read-through of premature termination codons.
Zilberberg A; Lahav L; Rosin-Arbesfeld R
Gut; 2010 Apr; 59(4):496-507. PubMed ID: 19951906
[TBL] [Abstract][Full Text] [Related]
34. Transdermal delivery of a readthrough-inducing drug: a new approach of gentamicin administration for the treatment of nonsense mutation-mediated disorders.
Shiozuka M; Wagatsuma A; Kawamoto T; Sasaki H; Shimada K; Takahashi Y; Nonomura Y; Matsuda R
J Biochem; 2010 Apr; 147(4):463-70. PubMed ID: 19910311
[TBL] [Abstract][Full Text] [Related]
35. Translational readthrough induction of pathogenic nonsense mutations.
Kellermayer R
Eur J Med Genet; 2006; 49(6):445-50. PubMed ID: 16740421
[TBL] [Abstract][Full Text] [Related]
36. Expression studies of mutant factor VIII alleles with premature termination codons with regard to inhibitor formation.
Zimmermann MA; Oldenburg J; Müller CR; Rost S
Haemophilia; 2014 May; 20(3):e215-21. PubMed ID: 24602271
[TBL] [Abstract][Full Text] [Related]
37. Enhanced production of functional proteins from defective genes.
Xi B; Guan F; Lawrence DS
J Am Chem Soc; 2004 May; 126(18):5660-1. PubMed ID: 15125646
[TBL] [Abstract][Full Text] [Related]
38. Stop-codon read-through for patients affected by a lysosomal storage disorder.
Brooks DA; Muller VJ; Hopwood JJ
Trends Mol Med; 2006 Aug; 12(8):367-73. PubMed ID: 16798086
[TBL] [Abstract][Full Text] [Related]
39. Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations.
Wilschanski M; Yahav Y; Yaacov Y; Blau H; Bentur L; Rivlin J; Aviram M; Bdolah-Abram T; Bebok Z; Shushi L; Kerem B; Kerem E
N Engl J Med; 2003 Oct; 349(15):1433-41. PubMed ID: 14534336
[TBL] [Abstract][Full Text] [Related]
40. alpha-L-iduronidase premature stop codons and potential read-through in mucopolysaccharidosis type I patients.
Hein LK; Bawden M; Muller VJ; Sillence D; Hopwood JJ; Brooks DA
J Mol Biol; 2004 Apr; 338(3):453-62. PubMed ID: 15081804
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
